Study #2019-1233
An exploratory phase 1b open-label multiarm trial to evaluate the safety and efficacy of CC-90009 in combination with anti-leukemia agents in subjects with acute myeloid leukemia
MD Anderson Study Status
Not Accepting
Treatment Agent
CC-90009, Venetoclax, Azacitidine, Gilteritinib
Description
CC-90009-AML-002 is an exploratory Phase 1b open-label multi-arm trial to evaluate the safety and efficacy of CC-90009 in combination with anti-leukemia agents in subjects with acute myeloid leukemia (AML).
Information and next steps
Disease:
Leukemia, Myeloid, Acute
Study phase:
I/II
Physician name:
Courtney DiNardo
Department:
Leukemia
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Due to our response to COVID-19, all blood donations at MD Anderson
Blood Donor Center locations are being held by appointment only.